Overview

Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
0
Participant gender:
All
Summary
Comparison of 6% hydroxyethyl starch 130/0.4 with 5% albumin as priming solution for cardiopulmonary bypass
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Yonsei University
Treatments:
Hydroxyethyl Starch Derivatives
Criteria
Inclusion Criteria:

- Mitral valvular heart disease

Exclusion Criteria:

- Status of Infection

- Re-operation

- Liver failure

- Renal disease

- Administration of steroid